BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 26529046)

  • 1. Nucleoside Reverse Transcriptase Inhibitors Suppress Laser-Induced Choroidal Neovascularization in Mice.
    Mizutani T; Fowler BJ; Kim Y; Yasuma R; Krueger LA; Gelfand BD; Ambati J
    Invest Ophthalmol Vis Sci; 2015 Nov; 56(12):7122-9. PubMed ID: 26529046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of laser-induced choroidal neovascularization by a CCR3 antagonist.
    Mizutani T; Ashikari M; Tokoro M; Nozaki M; Ogura Y
    Invest Ophthalmol Vis Sci; 2013 Feb; 54(2):1564-72. PubMed ID: 23404125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of experimental choroidal neovascularization in mice by anti-VEGFA/VEGFR2 or non-specific siRNA.
    Gu L; Chen H; Tuo J; Gao X; Chen L
    Exp Eye Res; 2010 Sep; 91(3):433-9. PubMed ID: 20599960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of laser-induced choroidal neovascularization by nontargeted siRNA.
    Ashikari M; Tokoro M; Itaya M; Nozaki M; Ogura Y
    Invest Ophthalmol Vis Sci; 2010 Jul; 51(7):3820-4. PubMed ID: 20130283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Clinical Metabolite of Azidothymidine Inhibits Experimental Choroidal Neovascularization and Retinal Pigmented Epithelium Degeneration.
    Narendran S; Pereira F; Yerramothu P; Apicella I; Wang SB; Varshney A; Baker KL; Marion KM; Ambati M; Ambati VL; Ambati K; Sadda SR; Gelfand BD; Ambati J
    Invest Ophthalmol Vis Sci; 2020 Aug; 61(10):4. PubMed ID: 32749462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of choroidal neovascularization by inhibiting angiotensin-converting enzyme: minimal role of bradykinin.
    Nagai N; Oike Y; Izumi-Nagai K; Koto T; Satofuka S; Shinoda H; Noda K; Ozawa Y; Inoue M; Tsubota K; Ishida S
    Invest Ophthalmol Vis Sci; 2007 May; 48(5):2321-6. PubMed ID: 17460297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiostatic effect of CXCR3 expressed on choroidal neovascularization.
    Fujimura S; Takahashi H; Yuda K; Ueta T; Iriyama A; Inoue T; Kaburaki T; Tamaki Y; Matsushima K; Yanagi Y
    Invest Ophthalmol Vis Sci; 2012 Apr; 53(4):1999-2006. PubMed ID: 22408007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockage of PI3K/mTOR Pathways Inhibits Laser-Induced Choroidal Neovascularization and Improves Outcomes Relative to VEGF-A Suppression Alone.
    Ma J; Sun Y; López FJ; Adamson P; Kurali E; Lashkari K
    Invest Ophthalmol Vis Sci; 2016 Jun; 57(7):3138-44. PubMed ID: 27304845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of choroidal neovascularization in lectin-like oxidized low-density lipoprotein receptor type 1-deficient mice.
    Inomata Y; Fukushima M; Hara R; Takahashi E; Honjo M; Koga T; Kawaji T; Satoh H; Takeya M; Sawamura T; Tanihara H
    Invest Ophthalmol Vis Sci; 2009 Aug; 50(8):3970-6. PubMed ID: 19182261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mobile Laser Indirect Ophthalmoscope: For the Induction of Choroidal Neovascularization in a Mouse Model.
    Weinberger D; Bor-Shavit E; Barliya T; Dahbash M; Kinrot O; Gaton DD; Nisgav Y; Livnat T
    Curr Eye Res; 2017 Nov; 42(11):1545-1551. PubMed ID: 28933966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-dependent effect of pitavastatin on VEGF and angiogenesis in a mouse model of choroidal neovascularization.
    Zambarakji HJ; Nakazawa T; Connolly E; Lane AM; Mallemadugula S; Kaplan M; Michaud N; Hafezi-Moghadam A; Gragoudas ES; Miller JW
    Invest Ophthalmol Vis Sci; 2006 Jun; 47(6):2623-31. PubMed ID: 16723479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutrophils promote experimental choroidal neovascularization.
    Zhou J; Pham L; Zhang N; He S; Gamulescu MA; Spee C; Ryan SJ; Hinton DR
    Mol Vis; 2005 Jun; 11():414-24. PubMed ID: 15988410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Semaphorin 3A blocks the formation of pathologic choroidal neovascularization induced by transforming growth factor beta.
    Bai Y; Liang S; Yu W; Zhao M; Huang L; Zhao M; Li X
    Mol Vis; 2014; 20():1258-70. PubMed ID: 25352735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of experimental choroidal neovascularization and resolution of active lesions by VEGF trap in nonhuman primates.
    Nork TM; Dubielzig RR; Christian BJ; Miller PE; Miller JM; Cao J; Zimmer EP; Wiegand SJ
    Arch Ophthalmol; 2011 Aug; 129(8):1042-52. PubMed ID: 21825187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factor-β inhibition decreases diode laser-induced choroidal neovascularization development in rats: P17 and P144 peptides.
    Recalde S; Zarranz-Ventura J; Fernández-Robredo P; García-Gómez PJ; Salinas-Alamán A; Borrás-Cuesta F; Dotor J; García-Layana A
    Invest Ophthalmol Vis Sci; 2011 Sep; 52(10):7090-7. PubMed ID: 21810978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lactic Acid Upregulates VEGF Expression in Macrophages and Facilitates Choroidal Neovascularization.
    Song J; Lee K; Park SW; Chung H; Jung D; Na YR; Quan H; Cho CS; Che JH; Kim JH; Park JH; Seok SH
    Invest Ophthalmol Vis Sci; 2018 Jul; 59(8):3747-3754. PubMed ID: 30046816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue kallikrein attenuates choroidal neovascularization via cleavage of vascular endothelial growth factor.
    Fukuhara J; Noda K; Murata M; Namba S; Kinoshita S; Dong Z; Ando R; Lennikov A; Kanda A; Ishida S
    Invest Ophthalmol Vis Sci; 2013 Jan; 54(1):274-9. PubMed ID: 23233257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baicalin attenuates laser-induced choroidal neovascularization.
    Yang SJ; Jo H; Kim JG; Jung SH
    Curr Eye Res; 2014 Jul; 39(7):745-51. PubMed ID: 24502359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue Plasminogen Activator as an Antiangiogenic Agent in Experimental Laser-Induced Choroidal Neovascularization in Mice.
    Ozone D; Mizutani T; Nozaki M; Ohbayashi M; Hasegawa N; Kato A; Yasukawa T; Ogura Y
    Invest Ophthalmol Vis Sci; 2016 Oct; 57(13):5348-5354. PubMed ID: 27727399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repurposing bortezomib for choroidal neovascularization treatment via antagonizing VEGF-A and PDGF-D mediated signaling.
    Liu Y; Feng M; Cai J; Li S; Dai X; Shan G; Wu S
    Exp Eye Res; 2021 Mar; 204():108446. PubMed ID: 33476605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.